Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.00 |
|---|---|
| High | 7.60 |
| Low | 7.60 |
| Bid | -- |
| Offer | -- |
| Previous close | 7.60 |
| Average volume | -- |
|---|---|
| Shares outstanding | 9.06m |
| Free float | 8.30m |
| P/E (TTM) | -- |
| Market cap | 6.80m USD |
| EPS (TTM) | -10.37 USD |
Data delayed at least 15 minutes, as of Dec 02 2024 14:43 GMT.
More ▼
Announcements
- Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
- Mainz Biomed Provides Review of 2025 Highlights
- DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio
- Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
- Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
- Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
- Mainz Biomed to Attend 2025 Maxim Growth Summit
- Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
- Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
- Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
More ▼
